Anti-VEGF-Therapie bei fibrovaskulärer und serös-vaskularisierter Pigmentepithelabhebung bei neovaskulärer AMD: Eine retrospektive Fünf-Jahres-Analyse

BACKGROUND: Neovascular age-related macular degeneration (nAMD) is the most frequent cause of pigment epithelial detachment (PED). In the clinical routine the treatment of fibrovascular PED (fPED) and serous vascularized PED (svPED) with intravitreal vascular endothelial growth factor (VEGF) inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, T., Reiners, M., Zeman, F., Greslechner, R., Helbig, H., Gamulescu, M.-A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Originalien
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648623/
https://www.ncbi.nlm.nih.gov/pubmed/33320292
http://dx.doi.org/10.1007/s00347-020-01297-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648623/
https://www.ncbi.nlm.nih.gov/pubmed/33320292
http://dx.doi.org/10.1007/s00347-020-01297-x

Ejemplares similares